Efficacy, safety, and biomarker analysis of neoadjuvant avelumab/axitinib in patients (pts) with localized renal cell carcinoma (RCC) who are at high risk of relapse after nephrectomy (NeoAvAx). This ...

Patients with renal-cell carcinoma who undergo nephrectomy have no options for adjuvant therapy to reduce the risk of recurrence that have high levels of supporting evidence. In a double-blind, phase ...

In the treatment of small renal masses, robotic partial nephrectomy (RPN) has a superior morbidity profile compared with laparoscopic partial nephrectomy (LPN), according to an updated meta-analysis ...

Patients with renal-cell carcinoma who undergo nephrectomy have few options for adjuvant therapy to reduce the recurrence risk; nearly half will eventually have recurrence and substantially shortened ...

Partial and radical nephrectomy for T3a RCC have similar 5-year rates of overall and cancer-specific survival, according to a propensity score-matched analysis. WASHINGTON, DC—Partial nephrectomy (PN) ...

The probability of surgical success with telesurgery for radical prostatectomy and partial nephrectomy for small renal masses was non-inferior to local robotic surgery in a small randomized trial. The ...